A detailed history of Clearbridge Investments, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Clearbridge Investments, LLC holds 1,702,393 shares of IONS stock, worth $62.2 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,702,393
Previous 2,160,270 21.2%
Holding current value
$62.2 Million
Previous $103 Million 33.76%
% of portfolio
0.06%
Previous 0.09%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$40.06 - $51.86 $18.3 Million - $23.7 Million
-457,877 Reduced 21.2%
1,702,393 $68.2 Million
Q2 2024

Aug 14, 2024

SELL
$36.45 - $47.7 $84.1 Million - $110 Million
-2,305,921 Reduced 51.63%
2,160,270 $103 Million
Q1 2024

May 13, 2024

SELL
$42.03 - $53.55 $10.1 Million - $12.9 Million
-241,289 Reduced 5.13%
4,466,191 $194 Million
Q4 2023

Feb 09, 2024

SELL
$43.39 - $51.63 $5.78 Million - $6.88 Million
-133,215 Reduced 2.75%
4,707,480 $238 Million
Q3 2023

Nov 13, 2023

SELL
$38.5 - $47.13 $13.3 Million - $16.3 Million
-346,509 Reduced 6.68%
4,840,695 $220 Million
Q2 2023

Aug 11, 2023

SELL
$34.73 - $43.33 $7.1 Million - $8.86 Million
-204,377 Reduced 3.79%
5,187,204 $213 Million
Q1 2023

May 12, 2023

SELL
$33.58 - $41.2 $1.14 Million - $1.4 Million
-34,061 Reduced 0.63%
5,391,581 $193 Million
Q4 2022

Feb 10, 2023

SELL
$37.12 - $46.52 $12.9 Million - $16.2 Million
-348,250 Reduced 6.03%
5,425,642 $205 Million
Q3 2022

Nov 14, 2022

SELL
$36.54 - $48.66 $8.47 Million - $11.3 Million
-231,926 Reduced 3.86%
5,773,892 $255 Million
Q2 2022

Aug 11, 2022

SELL
$31.71 - $43.0 $14.9 Million - $20.2 Million
-470,215 Reduced 7.26%
6,005,818 $222 Million
Q1 2022

May 13, 2022

BUY
$29.88 - $37.04 $17.7 Million - $22 Million
593,051 Added 10.08%
6,476,033 $240 Million
Q4 2021

Feb 11, 2022

SELL
$25.61 - $35.1 $37 Million - $50.7 Million
-1,444,340 Reduced 19.71%
5,882,982 $179 Million
Q3 2021

Nov 12, 2021

BUY
$33.54 - $40.55 $17.2 Million - $20.8 Million
511,721 Added 7.51%
7,327,322 $246 Million
Q2 2021

Aug 13, 2021

SELL
$34.54 - $47.25 $20.3 Million - $27.8 Million
-587,366 Reduced 7.93%
6,815,601 $272 Million
Q1 2021

May 13, 2021

BUY
$42.51 - $63.78 $20.7 Million - $31.1 Million
487,820 Added 7.05%
7,402,967 $333 Million
Q4 2020

Feb 10, 2021

SELL
$45.3 - $60.27 $16.2 Million - $21.6 Million
-358,218 Reduced 4.93%
6,915,147 $391 Million
Q3 2020

Nov 12, 2020

SELL
$47.45 - $62.95 $18.5 Million - $24.5 Million
-388,859 Reduced 5.08%
7,273,365 $345 Million
Q2 2020

Aug 14, 2020

SELL
$46.85 - $61.05 $17.4 Million - $22.7 Million
-372,040 Reduced 4.63%
7,662,224 $452 Million
Q1 2020

May 15, 2020

BUY
$41.6 - $63.4 $3.61 Million - $5.5 Million
86,688 Added 1.09%
8,034,264 $380 Million
Q4 2019

Feb 14, 2020

SELL
$53.85 - $65.27 $72.3 Million - $87.7 Million
-1,343,348 Reduced 14.46%
7,947,576 $484 Million
Q3 2019

Nov 14, 2019

SELL
$59.06 - $72.15 $12.5 Million - $15.2 Million
-211,108 Reduced 2.22%
9,290,924 $557 Million
Q2 2019

Aug 14, 2019

BUY
$62.09 - $86.14 $231,098 - $320,613
3,722 Added 0.04%
9,502,032 $0
Q1 2019

May 15, 2019

SELL
$52.92 - $81.17 $46.7 Million - $71.6 Million
-882,009 Reduced 8.5%
9,498,310 $771 Million
Q4 2018

Feb 14, 2019

BUY
$43.37 - $59.54 $6.22 Million - $8.54 Million
143,380 Added 1.4%
10,380,319 $561 Million
Q3 2018

Nov 14, 2018

SELL
$42.88 - $53.7 $25 Million - $31.3 Million
-583,181 Reduced 5.39%
10,236,939 $528 Million
Q2 2018

Aug 14, 2018

SELL
$40.53 - $50.7 $4.05 Million - $5.07 Million
-99,989 Reduced 0.92%
10,820,120 $451 Million
Q1 2018

May 15, 2018

SELL
$44.08 - $55.05 $2.85 Million - $3.56 Million
-64,709 Reduced 0.59%
10,920,109 $481 Million
Q4 2017

Feb 14, 2018

SELL
$50.3 - $64.39 $22.9 Million - $29.3 Million
-455,033 Reduced 3.98%
10,984,818 $553 Million
Q3 2017

Nov 14, 2017

SELL
$45.56 - $59.57 $17.7 Million - $23.1 Million
-388,030 Reduced 3.28%
11,439,851 $580 Million
Q2 2017

Aug 14, 2017

BUY
N/A
11,827,881
11,827,881 $602 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.19B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Clearbridge Investments, LLC Portfolio

Follow Clearbridge Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearbridge Investments, LLC with notifications on news.